Company: BGLC
Filing Date: 2025-08-18
Form Type: 10-Q
Source: 0001477932-25-006023
Chunk: 0

Company: BioNexus Gene Lab Corp
Filing Date: 2025-08-18
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
BIONEXUS GENE LAB CORP. 

CONDENSED CONSOLIDATED BALANCE SHEETS 

AS OF JUNE 30, 2025 AND DECEMBER 31, 2024 

(Currency expressed in United States Dollars (“US$”))

     As of   Note  June 30,  December 31,      2025  2024      (Unaudited)  (Audited) ASSETS         CURRENT ASSETS         Cash and bank balances     814,179   1,583,479 Fixed deposits placed with financial institutions (including $1,521,689 and $1,490,461 of fixed deposits with original maturities more than 3 months as of June 30, 2025 and December 31, 2024 respectively)     2,244,699   2,793,948 Trade receivables, net of allowance for credit losses of $494,668 and $517,877 as of June 30, 2025 and December 31, 2024 respectively (including $16,463 and $47,272 of trade receivables from related parties as of June 30, 2025 and December 31, 2024 respectively)  3   1,852,085   1,376,571 Other receivables, deposits and prepayments      151,269   203,660 Tax recoverable  4   101,471   84,167 Inventories (including goods in transit of $Nil and $188,797 as of June 30, 2025 and December 31, 2024 respectively)       1,215,623   1,388,624 Total current assets      6,379,326   7,430,449              NON-CURRENT ASSETS            Operating lease right-of-use assets  5   200,284   215,243 Property, plant and equipment, net  6   1,592,907   1,522,990 Investments in equity securities  7   1,248,688   1,265,166 Total non-current assets      3,041,879   3,003,399 TOTAL ASSETS     $9,421,205  $10,